Key statistics
As of last trade NewAmsterdam Pharma Company NV (NAMS:NMQ) traded at 34.76, -17.25% below its 52-week high of 42.00, set on Nov 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 35.26 |
|---|---|
| High | 35.55 |
| Low | 34.47 |
| Bid | 34.52 |
| Offer | 34.90 |
| Previous close | 34.63 |
| Average volume | 584.71k |
|---|---|
| Shares outstanding | 113.39m |
| Free float | 112.86m |
| P/E (TTM) | -- |
| Market cap | 3.93bn USD |
| EPS (TTM) | -2.02 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 18:25 GMT.
More ▼
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
- NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
- NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in November
- NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
More ▼
